Defense World
30 Dec 2025, 10:16 UTC · 38w ago
Verdict
Headline takes no side. We score MRUS +0.40 across two claims — moderately bullish.
+0.40moderately bullish
More positive than 63% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish
Major shareholder Genmab acquired 15,710 shares of Merus N.V. (MRUS) on December 22nd.
More positive than 63% of claims this week
The shares were purchased at an average cost of $97.00 per share, totaling approximately $1.52 million.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More positive than 41% of claims this week
Which stocks this story touches
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
5h ago
+0.0%
Price flat so far
$90.00 vs $90.00 close before publication (Dec 29) · not market-adjusted
MRUS chart →
